Skip to main content
S 2814 117th Congress Senate Health

Vital Medication Affordability Act

Introduced: September 23, 2021 Introduced by: Kennedy, John Republican · Louisiana See on congress.gov
Sign in to write a letter Sign in to watch
 Everywhere this bill has been 2 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Sep 23, 2021
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Sep 23, 2021
Introduced in Senate
 Plain-English summary Congressional Research Service

Vital Medication Affordability Act

This bill establishes pricing for insulin and injectable epinephrine provided at federally qualified health centers (community-based health providers in underserved areas) that participate in the 340B drug pricing program.

Specifically, such centers must provide insulin and injectable epinephrine at or below the price paid by the center, plus a minimal administration fee, to patients with a household income that is not more than 350% of the federal poverty level and who either

  • have a health insurance plan with a cost-sharing requirement of more than 20% of the total amount charged for such drugs,
  • have a high unmet deductible under a health insurance plan, or
  • do not have a health insurance plan.
What's happening now September 23, 2021

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

 Committees of jurisdiction 1